Methylene Blue: Magic Bullet for Vasoplegia?
About this course
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
The International Anesthesia Research Society designates each Journal-Based CME activity (article) for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The IARS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Anesthesia & Analgesia, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
The International Anesthesia Research Society designates each CME activity for a maximum of 1 hour of AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The International Anesthesia Research Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
Jeffrey B. Gross, M.D., Editor, Anesthesia & Analgesia CME Program and Steven L. Shafer, M.D., Editor-in-Chief of Anesthesia & Analgesia, report that they have no financial relationships or interests to disclose relative to the content of the CME program. The links attached to each name will direct you to the disclosure statements by Drs. Gross and Shafer.
This CME program is supported entirely by the International Anesthesia Research Society. There is no commercial sponsorship of this program.
Following completion of this course, anesthesiologists will be able to appropriately use methylene blue to treat their patients who suffer from refractory hypotension.
Jeffrey B. Gross, M.D. (CME Editor): No conflicts
None of the authors of the cited articles has any conflicts of interest to disclose.